Get the latest Science News and Discoveries
A new anticoagulant with no risk of bleeding - EurekAlert
<strong>Anticoagulant treatments are crucial for managing many conditions, such as heart disease, stroke and venous thrombosis. Current options, however, carry an inherent risk of serious bleeding due to trauma or unforeseen events. A team from the University of Geneva (UNIGE) and the University of Sydney has developed a new anticoagulant, designed to have an on-demand reversible activity, with a fast-acting ‘‘antidote’’. This approach could revolutionise the use of anticoagulants in surgery or other applications. The mechanism of activation and deactivation of the active principle could also be used in immunotherapy. These results are published in <em>Nature Biotechnology</em>.</strong>
None
Or read this on Eureka Alert